Hunan Er Kang Pharmaceutical (300267) — Capital Reinvestment Ratio
Latest as of June 2023:
0.26x
Hunan Er Kang Pharmaceutical (300267) has a Capital Reinvestment Ratio of 0.26x as of June 2023, meaning it reinvests 0% of its operating cash flow (CN¥174.55 Million) in capital expenditures (CN¥45.68 Million). See 300267 cash flow after capex ratio to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.26x
Capex / Operating Cash Flow
Operating Cash Flow
CN¥174.55 Million
CNY
Capital Expenditures
CN¥45.68 Million
CNY
Data as of
Jun 2023
Most recent filing
Hunan Er Kang Pharmaceutical Capital Reinvestment Ratio (2008–2024)
This chart tracks Hunan Er Kang Pharmaceutical's Capital Reinvestment Ratio across 17 annual periods.
Annual Capital Reinvestment Ratio for Hunan Er Kang Pharmaceutical (2008–2024)
Year-by-year Capital Reinvestment Ratio for Hunan Er Kang Pharmaceutical from 2008 to 2024. For live market cap and broader valuation context, see Hunan Er Kang Pharmaceutical market cap and net worth.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 1.17x | CN¥166.69 Million | CN¥195.60 Million | ▼ -26.9% |
| 2023 | 1.60x | CN¥148.42 Million | CN¥238.19 Million | ▲ +159.9% |
| 2022 | 0.62x | CN¥281.02 Million | CN¥173.49 Million | ▼ -83.6% |
| 2021 | 3.77x | CN¥92.68 Million | CN¥349.33 Million | ▲ +11.1% |
| 2020 | 3.39x | CN¥178.53 Million | CN¥605.89 Million | ▲ +315.4% |
| 2019 | 0.82x | CN¥445.82 Million | CN¥364.21 Million | ▲ +4.6% |
| 2018 | 0.78x | CN¥123.89 Million | CN¥96.72 Million | ▲ +107.8% |
| 2017 | 0.38x | CN¥689.11 Million | CN¥258.92 Million | ▼ -84.0% |
| 2016 | 2.36x | CN¥486.50 Million | CN¥1.15 Billion | ▲ +114.2% |
| 2015 | 1.10x | CN¥518.96 Million | CN¥570.53 Million | ▼ -63.4% |
| 2014 | 3.01x | CN¥175.38 Million | CN¥527.42 Million | ▲ +156.9% |
| 2013 | 1.17x | CN¥174.22 Million | CN¥203.98 Million | ▼ -57.5% |
| 2012 | 2.75x | CN¥84.02 Million | CN¥231.28 Million | ▲ +375.1% |
| 2011 | 0.58x | CN¥75.72 Million | CN¥43.87 Million | ▼ -62.2% |
| 2010 | 1.53x | CN¥42.47 Million | CN¥65.05 Million | ▼ -20.6% |
| 2009 | 1.93x | CN¥10.18 Million | CN¥19.64 Million | ▼ -96.8% |
| 2008 | 59.81x | CN¥211.00K | CN¥12.62 Million | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow